Balance Sheet Mitsubishi Motors Corporation

Stocks

7211

JP3899800001

Auto & Truck Manufacturers

Market Closed - Japan Exchange Other stock markets 07:30:00 17/07/2026 BST			5-day change	1st Jan Change
380.40 ^JPY	-2.26%		+5.14%	+2.53%

07-16	Oil, Tech Outlooks Gyrate Asian Stock Markets	MT
07-10	Mitsubishi Motors Partners with University of Tokyo Startup to Mass-Produce Humanoid Robots	MT

548c00404d1b48.DcoQkyk6eLerq3DZ_7a4BiNM4Fxzhf690wbPym2vWwI.WaJS2mgOVdXq-TypkIXTcFA01hofy5HEkD-d-1XDNVB4nVagHwJI59_BAw

Published financial data: MITSUBISHI MOTORS CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	2,039B	2,458B	2,790B	2,788B	2,897B
Total Revenues	2,039B	2,458B	2,790B	2,788B	2,897B
Cost of Goods Sold, Total	1,676B	1,935B	2,221B	2,252B	2,447B
Gross Profit	362B	523B	569B	537B	449B
Selling General & Admin Expenses, Total	203B	257B	304B	311B	285B
Provision for Bad Debts	1.83B	-605M	-159M	348M	2.21B
R&D Expenses	57.51B	61.02B	57.64B	67.89B	64.86B
Depreciation & Amortization - (IS)	12.72B	14.52B	16.69B	18.89B	21.8B
Other Operating Expenses, Total	275B	332B	378B	398B	374B
Operating Income	87.33B	190B	191B	139B	75.52B
Interest Expense, Total	-5.08B	-3.56B	-6.05B	-6.73B	-6.1B
Interest And Investment Income	2.51B	8.3B	13.99B	12.62B	10.52B
Net Interest Expenses	-2.58B	4.74B	7.94B	5.89B	4.42B
Income (Loss) On Equity Invest.	8.53B	-12.21B	5.26B	-6.49B	1.35B
Currency Exchange Gains (Loss)	9.24B	5.42B	12.89B	-31.54B	2.94B
Other Non Operating Income (Expenses)	-1.56B	-6.43B	-8.02B	-8.08B	-5.33B
EBT, Excl. Unusual Items	101B	182B	209B	98.6B	78.91B
Gain (Loss) On Sale Of Investments	2.89B	24M	921M	-	-2.16B
Gain (Loss) On Sale Of Assets	2.84B	25.56B	362M	853M	996M
Asset Writedown	-4.34B	-6.96B	-4.64B	-10.04B	-19.19B
Other Unusual Items	-7.67B	-32.52B	-24.85B	-2.14B	-1.22B
EBT, Incl. Unusual Items	94.69B	168B	181B	87.26B	57.33B
Income Tax Expense	15.54B	-8.23B	20.27B	36.62B	36.17B
Earnings From Continuing Operations	79.15B	176B	161B	50.65B	21.16B
Net Income to Company	79.15B	176B	161B	50.65B	21.16B
Minority Interest	-5.11B	-7.63B	-5.85B	-9.66B	-11.14B
Net Income - (IS)	74.04B	169B	155B	40.99B	10.02B
Net Income to Common Incl Extra Items	74.04B	169B	155B	40.99B	10.02B
Net Income to Common Excl. Extra Items	74.04B	169B	155B	40.99B	10.02B
Per Share Items
Net EPS - Basic	49.76	113.38	103.97	28.7	7.48
Basic EPS - Continuing Operations	49.76	113.38	103.97	28.7	7.48
Basic Weighted Average Shares Outstanding	1.49B	1.49B	1.49B	1.43B	1.34B
Net EPS - Diluted	49.74	113.36	103.96	28.7	7.48
Diluted EPS - Continuing Operations	49.74	113.36	103.96	28.7	7.48
Diluted Weighted Average Shares Outstanding	1.49B	1.49B	1.49B	1.43B	1.34B
Normalized Basic EPS	38.98	71.32	83.87	36.38	28.52
Normalized Diluted EPS	38.96	71.3	83.86	36.38	28.52
Dividend Per Share	-	5	10	15	10
Payout Ratio	0.03	0.01	9.6	45.34	167.03
Supplemental Items
EBITDA	141B	251B	259B	213B	158B
EBITA	87.33B	190B	191B	139B	75.52B
EBIT	87.33B	190B	191B	139B	75.52B
Effective Tax Rate - (Ratio)	16.41	-4.9	11.21	41.96	63.1
Normalized Net Income	57.99B	106B	125B	51.96B	38.17B
Non-Cash Pension Expense	-1.45B	-1.03B	-604M	-4.41B	-437M
Supplemental Operating Expense Items
Advertising Expense	39.15B	51.54B	63.01B	60.21B	46.34B
Selling and Marketing Expenses	89B	124B	157B	156B	139B
Research And Development Expense From Footnotes	90.71B	107B	115B	127B	117B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	512B	596B	674B	453B	439B
Total Cash And Short Term Investments	512B	596B	674B	453B	439B
Accounts Receivable, Total	333B	405B	390B	420B	574B
Notes Receivable	624M	1.02B	7.03B	2.25B	-
Total Receivables	333B	406B	397B	422B	574B
Inventory	300B	352B	412B	363B	388B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	111B	121B	145B	153B	208B
Total Current Assets	1,256B	1,475B	1,628B	1,391B	1,610B
Net Property Plant And Equipment	429B	455B	498B	524B	551B
Long-term Investments	158B	155B	192B	198B	133B
Other Intangibles, Total	38.27B	40B	44.9B	51.17B	49.42B
Loans Receivable Long-Term	2.82B	2.76B	5.01B	2.91B	-
Deferred Tax Assets Long-Term	43.67B	74.03B	86.31B	78.82B	74.51B
Other Long-Term Assets, Total	1M	-	3M	1M	2M
Total Assets	1,928B	2,202B	2,454B	2,246B	2,418B
Liabilities
Accounts Payable, Total	586B	695B	672B	674B	781B
Short-term Borrowings	64.78B	78.83B	112B	70.15B	99.9B
Current Portion of Long-Term Debt	292B	73.1B	225B	83.43B	118B
Current Portion of Leases	3.75B	3.52B	3.72B	3.87B	5.38B
Current Income Taxes Payable	8.49B	13.51B	9.54B	12.18B	8.25B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	129B	143B	154B	161B	154B
Total Current Liabilities	1,084B	1,007B	1,175B	1,004B	1,167B
Long-Term Debt	95.77B	248B	128B	130B	141B
Long-Term Leases	24.1B	24.78B	24.69B	26.88B	31.85B
Pension & Other Post Retirement Benefits	32.24B	36.69B	20.37B	40.58B	37.75B
Deferred Tax Liability Non Current	17.13B	320M	203M	92M	-
Other Non Current Liabilities	44.73B	53.92B	61.77B	70.41B	77.97B
Total Liabilities	1,298B	1,371B	1,410B	1,272B	1,455B
Common Stock, Total	284B	284B	284B	284B	284B
Additional Paid In Capital	200B	200B	200B	186B	186B
Retained Earnings	170B	338B	478B	501B	451B
Treasury Stock	-1.38B	-989M	-1.69B	-56.38B	-56.31B
Comprehensive Income and Other	-45.56B	-20.27B	49.72B	20.02B	54.6B
Total Common Equity	607B	801B	1,010B	934B	919B
Minority Interest	23.33B	29.21B	34.22B	39.16B	43.85B
Total Equity	630B	830B	1,044B	974B	963B
Total Liabilities And Equity	1,928B	2,202B	2,454B	2,246B	2,418B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.49B	1.49B	1.49B	1.34B	1.34B
ECS Total Common Shares Outstanding	1.49B	1.49B	1.49B	1.34B	1.34B
Book Value / Share	407.95	538.3	679.47	698.28	687.01
Tangible Book Value	569B	761B	965B	883B	870B
Tangible Book Value Per Share	382.22	511.42	649.26	660.04	650.09
Total Debt	481B	428B	492B	315B	395B
Net Debt	-30.97B	-168B	-182B	-138B	-43.47B
Debt Equivalent of Unfunded Proj. Benefit Obligation	27.46B	32.64B	3.14B	31.29B	25.34B
Minority Interest, Total (Incl. Fin. Div)	23.33B	29.21B	34.22B	39.16B	43.85B
Inventories - Raw Materials, Total	54.03B	66.9B	69.72B	70.49B	75.29B
Inventories - Work In Process, Total	53.27B	24.84B	24.68B	26.5B	27.86B
Inventories - Finished Goods, Total	192B	260B	317B	266B	285B
Full Time Employees	28.8K	28.43K	28.98K	28.57K	27.7K
Accumulated Allowance for Doubtful Accounts (Supple)	9.46B	5.77B	1.33B	1.5B	3.15B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	94.69B	168B	181B	87.26B	57.33B
Depreciation & Amortization - CF	53.63B	60.13B	67.74B	73.99B	82.63B
Depreciation & Amortization, Total	53.63B	60.13B	67.74B	73.99B	82.63B
(Gain) Loss From Sale Of Asset	1.5B	-18.6B	4.28B	9.21B	2.19B
(Gain) Loss on Sale of Investments - (CF)	-2.79B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-8.53B	12.21B	-5.26B	6.49B	-1.35B
Other Operating Activities, Total	-2.04B	-27.22B	-25.98B	-22.46B	-30.87B
Change In Accounts Receivable	62.68B	-62.78B	29.26B	-29.86B	-143B
Change In Inventories	-13.1B	-38.74B	-25.75B	43.46B	13.49B
Change In Accounts Payable	-85.61B	70.34B	-57.83B	6.74B	79.04B
Change in Other Net Operating Assets	17.68B	10.11B	-26.49B	-92M	-23.6B
Cash from Operations	118B	174B	141B	175B	35.76B
Capital Expenditure	-76.54B	-71.04B	-114B	-95.08B	-113B
Sale of Property, Plant, and Equipment	4.82B	36.39B	1.77B	645M	1.97B
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-10.65B	-8.6B	-12.88B	-16.1B	-10.26B
Investment in Marketable and Equity Securities, Total	11.07B	-2M	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	2.18B	-9.89B	-13.79B	-4.22B	-1.51B
Cash from Investing	-69.12B	-53.14B	-139B	-115B	-122B
Short Term Debt Issued, Total	14.7B	13.3B	34.77B	4B	47.05B
Long-Term Debt Issued, Total	45.78B	239B	118B	215B	136B
Total Debt Issued	60.48B	252B	152B	219B	183B
Short Term Debt Repaid, Total	-	-	-4B	-44.71B	-17.5B
Long-Term Debt Repaid, Total	-65.77B	-307B	-87.44B	-353B	-91.92B
Total Debt Repaid	-65.77B	-307B	-91.44B	-398B	-109B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-	-	-	-68.64B	-
Common Dividends Paid	-21M	-16M	-14.84B	-18.58B	-16.73B
Common & Preferred Stock Dividends Paid	-21M	-16M	-14.84B	-18.58B	-16.73B
Other Financing Activities, Total	-4.92B	-7.14B	-8.42B	-8.68B	-9.52B
Cash from Financing	-10.23B	-61.86B	37.67B	-275B	46.9B
Foreign Exchange Rate Adjustments	28.1B	25.89B	38.66B	-9.31B	21.82B
Miscellaneous Cash Flow Adjustments	-1M	-	1M	-1M	6.72B
Net Change in Cash	66.85B	84.46B	78.27B	-224B	-11.25B
Supplemental Items
Cash Interest Paid	5.09B	3.62B	5.88B	6.79B	5.45B
Cash Income Tax Paid (Refund)	2.72B	32.31B	30.99B	24.1B	34.65B
Levered Free Cash Flow	7.03B	91.18B	-34.78B	71.54B	-132B
Unlevered Free Cash Flow	10.21B	93.4B	-30.99B	75.75B	-128B
Change In Net Working Capital	10.81B	6.15B	91.24B	-26.17B	135B
Net Debt Issued / Repaid	-5.29B	-54.71B	60.93B	-179B	73.14B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	2.88	5.77	5.13	3.69	2.02
Return on Total Capital	5.15	10.05	8.54	6.14	3.57
Return On Equity %	13.7	24.15	17.13	5.02	2.18
Return on Common Equity	13.28	23.96	17.08	4.22	1.08
Margin Analysis
Gross Profit Margin %	17.78	21.27	20.39	19.25	15.51
SG&A Margin	9.96	10.47	10.89	11.15	9.83
EBITDA Margin %	6.91	10.2	9.27	7.63	5.46
EBITA Margin %	4.28	7.75	6.85	4.98	2.61
EBIT Margin %	4.28	7.75	6.85	4.98	2.61
Income From Continuing Operations Margin %	3.88	7.17	5.76	1.82	0.73
Net Income Margin %	3.63	6.86	5.55	1.47	0.35
Net Avail. For Common Margin %	3.63	6.86	5.55	1.47	0.35
Normalized Net Income Margin	2.84	4.32	4.47	1.86	1.32
Levered Free Cash Flow Margin	0.34	3.71	-1.25	2.57	-4.56
Unlevered Free Cash Flow Margin	0.5	3.8	-1.11	2.72	-4.43
Asset Turnover
Asset Turnover	1.08	1.19	1.2	1.19	1.24
Fixed Assets Turnover	4.85	5.56	5.86	5.45	5.39
Receivables Turnover (Average Receivables)	5.57	6.66	7.02	6.89	5.83
Inventory Turnover (Average Inventory)	6.1	5.94	5.82	5.81	6.51
Short Term Liquidity
Current Ratio	1.16	1.46	1.39	1.39	1.38
Quick Ratio	0.78	0.99	0.91	0.87	0.87
Operating Cash Flow to Current Liabilities	0.11	0.17	0.12	0.17	0.03
Days Sales Outstanding (Average Receivables)	65.56	54.77	52.16	53.01	62.64
Days Outstanding Inventory (Average Inventory)	59.82	61.4	62.91	62.83	56.05
Average Days Payable Outstanding	128.96	117.63	109.71	111.5	107.4
Cash Conversion Cycle (Average Days)	-3.58	-1.46	5.37	4.34	11.28
Long Term Solvency
Total Debt/Equity	76.24	51.58	47.14	32.33	41.05
Total Debt / Total Capital	43.26	34.03	32.04	24.43	29.1
LT Debt/Equity	19.02	32.86	14.6	16.16	17.92
Long-Term Debt / Total Capital	10.79	21.68	9.92	12.21	12.7
Total Liabilities / Total Assets	67.32	62.28	57.45	56.65	60.16
EBIT / Interest Expense	17.17	53.53	31.54	20.62	12.38
EBITDA / Interest Expense	27.72	70.42	42.73	31.61	25.93
(EBITDA - Capex) / Interest Expense	12.67	50.46	23.91	17.49	7.46
Total Debt / EBITDA	3.41	1.71	1.9	1.48	2.5
Net Debt / EBITDA	-0.22	-0.67	-0.7	-0.65	-0.27
Total Debt / (EBITDA - Capex)	7.46	2.38	3.4	2.67	8.69
Net Debt / (EBITDA - Capex)	-0.48	-0.93	-1.26	-1.17	-0.96
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	40.09	20.56	13.48	-0.05	3.88
Gross Profit, 1 Yr. Growth %	131.66	44.24	8.81	-5.65	-16.32
EBITDA, 1 Yr. Growth %	-579.4	77.8	3.22	-17.74	-25.69
EBITA, 1 Yr. Growth %	-191.62	118.13	0.25	-27.3	-45.6
EBIT, 1 Yr. Growth %	-191.62	118.13	0.25	-27.3	-45.6
Earnings From Cont. Operations, 1 Yr. Growth %	-125.58	122.82	-8.96	-68.46	-58.23
Net Income, 1 Yr. Growth %	-123.71	127.9	-8.31	-73.51	-75.57
Normalized Net Income, 1 Yr. Growth %	-184.49	83.01	17.59	-58.36	-26.54
Diluted EPS Before Extra, 1 Yr. Growth %	-123.7	127.91	-8.29	-72.4	-73.93
Accounts Receivable, 1 Yr. Growth %	-16.72	21.66	-3.64	7.57	36.85
Inventory, 1 Yr. Growth %	19.86	17.35	17.15	-11.82	6.93
Net Property, Plant and Equip., 1 Yr. Growth %	4.49	5.86	9.58	5.27	5.11
Total Assets, 1 Yr. Growth %	3.89	14.16	11.49	-8.5	7.67
Tangible Book Value, 1 Yr. Growth %	19.89	33.84	26.82	-8.5	-1.49
Common Equity, 1 Yr. Growth %	19.42	32	26.1	-7.51	-1.6
Cash From Operations, 1 Yr. Growth %	-384.36	46.96	-18.88	24.1	-79.54
Capital Expenditures, 1 Yr. Growth %	-3.69	-7.19	60.42	-16.57	18.47
Levered Free Cash Flow, 1 Yr. Growth %	-120.53	1.2K	-138.14	-305.73	-284.56
Unlevered Free Cash Flow, 1 Yr. Growth %	-133.04	814.76	-133.18	-344.43	-269.27
Dividend Per Share, 1 Yr. Growth %	-	-	100	50	-33.33
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.23	29.96	16.97	6.5	1.9
Gross Profit, 2 Yr. CAGR %	3.63	82.8	25.28	1.32	-11.14
EBITDA, 2 Yr. CAGR %	26.87	191.95	35.47	-7.85	-21.81
EBITA, 2 Yr. CAGR %	161.33	41.37	47.88	-14.63	-37.12
EBIT, 2 Yr. CAGR %	161.33	41.37	47.88	-14.63	-37.12
Earnings From Cont. Operations, 2 Yr. CAGR %	89.43	-24.5	42.43	-46.41	-63.7
Net Income, 2 Yr. CAGR %	69.47	-26.5	44.56	-50.71	-74.56
Normalized Net Income, 2 Yr. CAGR %	207.68	24.35	46.69	-30.03	-44.69
Diluted EPS Before Extra, 2 Yr. CAGR %	69.46	-26.51	44.57	-49.69	-73.18
Accounts Receivable, 2 Yr. CAGR %	-9.25	0.65	8.27	1.82	21.33
Inventory, 2 Yr. CAGR %	4.68	18.6	17.25	1.64	-2.89
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.37	5.17	7.7	7.4	5.19
Total Assets, 2 Yr. CAGR %	-0.25	8.9	12.82	1	-0.74
Tangible Book Value, 2 Yr. CAGR %	-11.34	26.68	30.29	7.72	-5.06
Common Equity, 2 Yr. CAGR %	-11.39	25.55	29.01	8	-4.6
Cash From Operations, 2 Yr. CAGR %	150.75	104.42	9.18	0.33	-49.61
Capital Expenditures, 2 Yr. CAGR %	-17.16	-5.45	22.02	15.69	-0.58
Levered Free Cash Flow, 2 Yr. CAGR %	-74.84	63.13	122.37	-11.42	94.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	-69.35	73.85	74.22	-9.94	103.41
Dividend Per Share, 2 Yr. CAGR %	-	-	-	73.21	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-6.75	2.69	24.22	11	5.62
Gross Profit, 3 Yr. CAGR %	-7.45	15.7	53.77	13.98	-4.94
EBITDA, 3 Yr. CAGR %	-6.78	41.98	106.44	14.72	-14.23
EBITA, 3 Yr. CAGR %	-7.91	146.05	26.06	16.71	-26.54
EBIT, 3 Yr. CAGR %	-7.91	146.05	26.06	16.71	-26.54
Earnings From Cont. Operations, 3 Yr. CAGR %	-16.3	99.97	-19.64	-13.83	-50.68
Net Income, 3 Yr. CAGR %	-17.71	87.06	-20.88	-17.89	-60.99
Normalized Net Income, 3 Yr. CAGR %	-7.29	158.75	22.05	-3.59	-28.88
Diluted EPS Before Extra, 3 Yr. CAGR %	-17.68	87.05	-20.88	-16.75	-59.59
Accounts Receivable, 3 Yr. CAGR %	-7.39	0.06	-0.8	8.04	12.36
Inventory, 3 Yr. CAGR %	8.52	8.74	18.12	6.63	3.37
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.73	-1.77	6.62	6.88	6.63
Total Assets, 3 Yr. CAGR %	-1.38	4.34	9.76	5.21	3.18
Tangible Book Value, 3 Yr. CAGR %	-11.92	1.7	26.72	15.81	4.56
Common Equity, 3 Yr. CAGR %	-11.38	1.2	25.73	15.47	4.7
Cash From Operations, 3 Yr. CAGR %	-6.83	109.84	50.22	13.94	-40.94
Capital Expenditures, 3 Yr. CAGR %	-14.67	-13.96	12.77	7.5	16.61
Levered Free Cash Flow, 3 Yr. CAGR %	-68.98	-6.38	0.5	116.68	13.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	-64.76	-4.92	0.1	95.04	11.14
Dividend Per Share, 3 Yr. CAGR %	-	-20.63	-	-	25.99
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.35	2.31	2.1	4.2	14.76
Gross Profit, 5 Yr. CAGR %	2.18	2.5	4.46	9.72	23.48
EBITDA, 5 Yr. CAGR %	22.1	10.7	8.26	19.43	40
EBITA, 5 Yr. CAGR %	76.36	14.17	11.3	61.11	-4.55
EBIT, 5 Yr. CAGR %	76.36	14.17	11.3	61.11	-4.55
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.65	10.67	3.53	18.09	-41.52
Net Income, 5 Yr. CAGR %	-17.9	9.41	3.09	9.72	-49.74
Normalized Net Income, 5 Yr. CAGR %	71.97	8.62	11.39	53.36	-11.07
Diluted EPS Before Extra, 5 Yr. CAGR %	-21.24	9.44	3.11	10.62	-48.67
Accounts Receivable, 5 Yr. CAGR %	15.27	18.3	-1.42	0.76	7.52
Inventory, 5 Yr. CAGR %	12.8	11.52	11.93	5.84	9.21
Net Property, Plant and Equip., 5 Yr. CAGR %	6.8	3.81	1.94	1.8	6.05
Total Assets, 5 Yr. CAGR %	5.37	5.87	4.07	2.99	5.43
Tangible Book Value, 5 Yr. CAGR %	-3.15	0.24	3.01	4.07	12.9
Common Equity, 5 Yr. CAGR %	-2.54	0.51	2.98	3.87	12.59
Cash From Operations, 5 Yr. CAGR %	20.85	7.73	-0.73	56.21	-2.95
Capital Expenditures, 5 Yr. CAGR %	6.27	-0.34	-1.55	-3.14	7.22
Levered Free Cash Flow, 5 Yr. CAGR %	-37.51	56.97	-31.8	-8.43	30.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-32.81	51.36	-33.22	-6.96	32.92
Dividend Per Share, 5 Yr. CAGR %	-	-21.71	-12.94	8.45	-